SLXN - Koefisien bali modal nimbang wutah Silexion

Simbol lan logo merek Silexion Therapeutics Corp (SLXN)

Silexion Therapeutics Corp (SLXN) is mitigating scientific risks by developing KRAS mutation therapies to combat various solid tumors. Business growth is driven by partnerships with RNA-drug laboratories and the acquisition of patents. However, capital shortages and the risk of clinical trial failure are weighing on the stock price. The P/E-to-growth trend reflects the market consensus, where the metric value stands at 0.00.

SLXN Rasio rega marang bathi tumrap wutah Silexion (17.08.2024 - 17.11.2026)

Rincian metrik lan analitis perusahaan Silexion Therapeutics Corp (SLXN)

- rega saiki lan proyeksi nilai saham:
Analisis fundamental perusahaan:Silexion Therapeutics Corp SLXN
Produk asli Silexion

The PEG ratio relates the market value of earnings to their growth rate, allowing for the identification of fundamental asset undervaluation when values fall below one. For Silexion Therapeutics Corp (SLXN), which minimizes capital expenditures by outsourcing RNA therapy development, the growth-adjusted P/E helps filter out volatility by assessing the efficiency of its asset-light operating model within the context of long-term capitalization potential.

Pesaing Silexion Therapeutics Corp

Rasio rega marang bathi tumrap wutah INCY (Incyte Corporation)|Rasio rega marang bathi tumrap wutah Hutchison MediPharma HCM|Koefisien bali modal nimbang wutah NUVB|DAWN - Rasio rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah Monopar Therapeutics Inc|Inhibrx Biosciences (INBX) - Rasio rega marang bathi tumrap wutah|Rasio P/E diaturake wutah IMAB|FENC (fennecpharma.com) - Pangali PEG|Pangali rega marang bathi tumrap wutah herontx.com (HRTX)|Rasio rega marang bathi tumrap wutah Nuvectis Pharma, Inc (NVCT)|CHRS - Rega marang bathi kanthi panyesuaian wutah|Rasio rega marang bathi tumrap wutah Corbus Pharma CRBP|Cardiff Oncology, Inc. - Rasio rega marang bathi tumrap wutah|BYSI - Rasio rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah bioatla.com|LIXT: Pangali PEG|Rasio rega marang wutah bathi resik Citius Pharmaceuticals CTXR|Pangali rega marang bathi tumrap wutah CLRB|Rega marang bathi kanthi panyesuaian wutah BioLineRx Ltd. BLRX|Pangali rega marang bathi tumrap wutah CANF (Can-Fite BioPharma)|APRE (Aprea) - Koefisien bali modal nimbang wutah|Kazia Therapeutics Limited - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang wutah bathi NCNA (NuCana Corp)|Chimerix, Inc - Pangali PEG|Koefisien bali modal nimbang wutah CYCC (Cyclacel Pharmaceuticals Inc.)|GTHX: Pangali PEG|Rega marang bathi kanthi panyesuaian wutah kronosbio.com (KRON)|Rasio rega marang bathi tumrap wutah Kintara Therapeutics, Inc.|ONCT: Koefisien bali modal nimbang wutah|Pangali PEG PRTG